Dist1 Inhibitors
Dist1, or Dishevelled-1, is a key protein involved in the Wnt signaling pathway, which plays a crucial role in embryonic development, cell proliferation, and differentiation. The protein functions as a central mediator in the transduction of Wnt signals from the cell surface to the nucleus, influencing gene expression and affecting a wide range of developmental processes and cellular functions. Dist1's role is pivotal in the context of both canonical (β-catenin dependent) and non-canonical (β-catenin independent) Wnt signaling pathways. In the canonical pathway, Dist1 contributes to the stabilization and accumulation of β-catenin in the cytoplasm, subsequently facilitating its translocation into the nucleus where it activates Wnt-responsive genes. In the non-canonical pathway, Dist1 is involved in processes such as cell movement and organization, acting through mechanisms that do not involve β-catenin. The multifunctional nature of Dist1, coupled with its participation in critical cellular pathways, underscores its significance in cellular homeostasis and development.
The inhibition of Dist1 represents a regulatory mechanism that can profoundly impact the Wnt signaling pathway and its associated cellular outcomes. Inhibition can occur through various mechanisms, including the binding of inhibitory proteins that prevent Dist1 from interacting with other signaling molecules within the pathway, post-translational modifications such as phosphorylation that alter Dist1's activity or localization, and the sequestration of Dist1 in cellular compartments where it is unable to participate in signaling. These inhibitory actions can lead to the suppression of Wnt signaling, resulting in decreased β-catenin stabilization and reduced transcriptional activation of Wnt target genes in the canonical pathway. In the non-canonical pathway, inhibition of Dist1 can affect cellular processes such as polarity and migration, illustrating the broad impact of Dist1 regulation. The precise control of Dist1 activity is therefore crucial for the proper function of the Wnt signaling pathway, highlighting the importance of understanding the mechanisms by which Dist1 is inhibited and the consequences of such inhibition on cellular and developmental processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
An EGFR tyrosine kinase inhibitor that blocks the ATP binding site of the receptor, thus inhibiting its activity and downstream signaling of proteins including RHBDF1. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
A selective EGFR tyrosine kinase inhibitor that prevents ATP from binding to the EGFR, leading to reduced signaling that can indirectly affect RHBDF1 functions. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
A dual tyrosine kinase inhibitor that targets both EGFR and HER2/neu receptors, potentially affecting signaling pathways involving RHBDF1. | ||||||
Afatinib | 439081-18-2 | sc-364398 sc-364398A | 5 mg 10 mg | $114.00 $198.00 | 13 | |
An irreversible inhibitor of the EGFR family that forms a covalent bond with cysteine residues in the ATP-binding site, diminishing EGFR-mediated signaling that could relate to RHBDF1. | ||||||
Pelitinib | 257933-82-7 | sc-208155 | 5 mg | $430.00 | ||
A potent irreversible inhibitor of EGFR tyrosine kinase, which may suppress EGFR-dependent RHBDF1 activity. | ||||||
Canertinib | 267243-28-7 | sc-207397 | 10 mg | $260.00 | 3 | |
An irreversible pan-EGFR inhibitor, targeting multiple EGFR family members and potentially modulating RHBDF1-associated pathways. | ||||||
Vandetanib | 443913-73-3 | sc-220364 sc-220364A | 5 mg 50 mg | $167.00 $1353.00 | ||
A tyrosine kinase inhibitor that targets the VEGFR and EGFR, which could influence pathways involving RHBDF1. | ||||||
Neratinib | 698387-09-6 | sc-364549 sc-364549A sc-364549B sc-364549C sc-364549D | 5 mg 25 mg 100 mg 500 mg 1 g | $92.00 $214.00 $383.00 $755.00 $1250.00 | 4 | |
An irreversible inhibitor of HER2 and EGFR kinases, affecting pathways that may include RHBDF1. | ||||||
AEE 788 | 497839-62-0 | sc-480425 | 10 mg | $4665.00 | ||
A dual inhibitor of EGFR and VEGFR tyrosine kinases, possibly affecting the signaling pathways related to RHBDF1. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $96.00 $421.00 | 16 | |
A selective EGFR tyrosine kinase inhibitor, which may lead to reduced EGFR signaling and indirectly modulate RHBDF1 activity. | ||||||